PL2044025T3 - Pochodne chinolinonu i ich kompozycje farmaceutyczne - Google Patents

Pochodne chinolinonu i ich kompozycje farmaceutyczne

Info

Publication number: PL2044025T3
Authority: PL; Poland
Prior art keywords: pharmaceutical compositions; quinolinone derivatives; quinolinone; derivatives; pharmaceutical
Prior art date: 2006-06-30

Application number

PL07819899T

Other languages

English (en)

Inventor

Olivier Lohse

Stéphanie Monnier

Jean-Louis Reber

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-30

Filing date

2007-07-02

Publication date

2013-02-28

2006-06-30 Priority claimed from GB0613159A external-priority patent/GB0613159D0/en

2006-06-30 Priority claimed from GB0613156A external-priority patent/GB0613156D0/en

2006-06-30 Priority claimed from GB0613160A external-priority patent/GB0613160D0/en

2006-06-30 Priority claimed from GB0613158A external-priority patent/GB0613158D0/en

2006-07-13 Priority claimed from EP06117129A external-priority patent/EP1878722A1/en

2007-07-02 Application filed by Novartis Ag filed Critical Novartis Ag

2013-02-28 Publication of PL2044025T3 publication Critical patent/PL2044025T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

PL07819899T 2006-06-30 2007-07-02 Pochodne chinolinonu i ich kompozycje farmaceutyczne PL2044025T3 (pl)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
GB0613159A GB0613159D0 (en)	2006-06-30	2006-06-30	Organic Compounds
GB0613156A GB0613156D0 (en)	2006-06-30	2006-06-30	Organic Compounds
GB0613160A GB0613160D0 (en)	2006-06-30	2006-06-30	Organic Compounds
GB0613158A GB0613158D0 (en)	2006-06-30	2006-06-30	Organic compounds
EP06117129A EP1878722A1 (en)	2006-07-13	2006-07-13	Quinolinone derivatives and their pharmaceutical compositions
EP07819899A EP2044025B1 (en)	2006-06-30	2007-07-02	Quinolinone derivatives and their pharmaceutical compositions
PCT/EP2007/056632 WO2008000839A1 (en)	2006-06-30	2007-07-02	Quinolinone derivatives and their pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
PL2044025T3 true PL2044025T3 (pl)	2013-02-28

Family

ID=38610531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07819899T PL2044025T3 (pl)	2006-06-30	2007-07-02	Pochodne chinolinonu i ich kompozycje farmaceutyczne

Country Status (28)

Country	Link
US (2)	US8198450B2 (pl)
EP (1)	EP2044025B1 (pl)
JP (1)	JP5253392B2 (pl)
KR (1)	KR101402398B1 (pl)
CN (1)	CN101479245B (pl)
AU (1)	AU2007264946B2 (pl)
BR (1)	BRPI0713951B8 (pl)
CA (1)	CA2654801C (pl)
CY (3)	CY1113733T1 (pl)
DK (1)	DK2044025T3 (pl)
ES (1)	ES2396987T3 (pl)
FI (2)	FIC20200047I1 (pl)
FR (2)	FR20C1054I1 (pl)
HR (1)	HRP20121074T1 (pl)
HU (2)	HUS2000043I1 (pl)
IL (1)	IL195796A (pl)
LT (2)	LTC2044025I2 (pl)
LU (2)	LUC00185I2 (pl)
MA (1)	MA30540B1 (pl)
MX (1)	MX2008016542A (pl)
MY (1)	MY150468A (pl)
NO (3)	NO341709B1 (pl)
NZ (1)	NZ573292A (pl)
PL (1)	PL2044025T3 (pl)
PT (1)	PT2044025E (pl)
SI (1)	SI2044025T1 (pl)
WO (1)	WO2008000839A1 (pl)
ZA (1)	ZA200809948B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2266656A1 (en)	1996-09-17	1998-03-26	Chiron Corporation	Compositions and methods for treating intracellular diseases
KR20120120453A (ko)	2007-09-05	2012-11-01	화이자 리미티드	Ｎ4-(2,2-다이플루오로-4ｈ-벤조〔1,4〕옥사진-3-온)-6-일〕-5-플루오로-ｎ2-〔3-(메틸아미노카보닐메틸렌옥시)페닐〕2,4-피리미딘다이아민의 지나포에이트 염
JOP20120023B1 (ar)	2011-02-04	2022-03-14	Novartis Ag	صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
US9452139B2 (en)	2013-03-14	2016-09-27	Novartis Ag	Respirable agglomerates of porous carrier particles and micronized drug
CA2898700C (en)	2013-03-14	2022-07-19	Novartis Ag	Deamorphization of spray-dried formulations via spray-blending
EP3347345B1 (en)	2015-09-29	2019-07-31	Inke, S.A.	Mixed solvate of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1h-quinolin-2-one l-tartrate
CN110724095B (zh) *	2019-09-12	2023-06-09	上海方予健康医药科技有限公司	一种茚达特罗乙酸盐的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05202301A (ja) *	1991-08-29	1993-08-10	Yamamoto Chem Inc	２−アニリノ−３−メチル−６−（Ｎ−ｎ−ブチル−Ｎ−シクロヘキシルアミノ）フルオランの結晶変態、その製造方法及びこの結晶変態を含有する記録材料
EP0688871A3 (en) *	1994-06-24	1998-07-08	Quest International B.V.	Preparation of phytosphingosine derivative
FR2777279B1 (fr) *	1998-04-08	2004-08-13	Hoechst Marion Roussel Inc	Nouvelles formes cristallines du 1s-[1alpha(2s,3r), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide
GB9913083D0 (en) *	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
GB0029562D0 (en) *	2000-12-04	2001-01-17	Novartis Ag	Organic compounds
GB0103926D0 (en)	2001-02-17	2001-04-04	Astrazeneca Ab	Chemical compounds
GB0127430D0 (en)	2001-11-15	2002-01-09	Smithkline Beecham Corp	Compounds
US7417051B2 (en) *	2002-04-12	2008-08-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments comprising betamimetics and a novel anticholinergic
US7250426B2 (en) *	2002-11-29	2007-07-31	Boehringer Ingelheim Pharma Gmbh & Co Kg	Tiotropium-containing pharmaceutical combination for inhalation
GB0303910D0 (en)	2003-02-20	2003-03-26	Merck Sharp & Dohme	Therapeutic agents
TWI324150B (en) *	2003-02-28	2010-05-01	Novartis Ag	Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt
PE20050211A1 (es)	2003-04-02	2005-04-27	Novartis Ag	Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas
CA2521271C (en)	2003-04-04	2011-01-04	Novartis Ag	Quinoline-2-one-derivatives for the treatment of airways diseases
JP2005343889A (ja)	2004-05-06	2005-12-15	Taisho Pharmaceut Co Ltd	イミダゾピリジン誘導体
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
GB0413960D0 (en)	2004-06-22	2004-07-28	Novartis Ag	Organic compounds
EP1869049B1 (en)	2005-03-21	2009-03-04	Eli Lilly And Company	Imidazopyridazine compounds
GB0511065D0 (en) *	2005-05-31	2005-07-06	Novartis Ag	Organic compounds
WO2007013673A1 (en)	2005-07-29	2007-02-01	Astellas Pharma Inc.	Fused heterocycles as lck inhibitors

2007
- 2007-07-02 MX MX2008016542A patent/MX2008016542A/es active IP Right Grant
- 2007-07-02 KR KR1020087031819A patent/KR101402398B1/ko active Active
- 2007-07-02 PT PT78198991T patent/PT2044025E/pt unknown
- 2007-07-02 DK DK07819899.1T patent/DK2044025T3/da active
- 2007-07-02 PL PL07819899T patent/PL2044025T3/pl unknown
- 2007-07-02 CA CA2654801A patent/CA2654801C/en active Active
- 2007-07-02 US US12/304,617 patent/US8198450B2/en active Active
- 2007-07-02 ES ES07819899T patent/ES2396987T3/es active Active
- 2007-07-02 JP JP2009517241A patent/JP5253392B2/ja active Active
- 2007-07-02 WO PCT/EP2007/056632 patent/WO2008000839A1/en not_active Ceased
- 2007-07-02 AU AU2007264946A patent/AU2007264946B2/en active Active
- 2007-07-02 EP EP07819899A patent/EP2044025B1/en active Active
- 2007-07-02 SI SI200731103T patent/SI2044025T1/sl unknown
- 2007-07-02 CN CN2007800244042A patent/CN101479245B/zh active Active
- 2007-07-02 NZ NZ573292A patent/NZ573292A/en unknown
- 2007-07-02 HR HRP20121074TT patent/HRP20121074T1/hr unknown
- 2007-07-02 BR BRPI0713951A patent/BRPI0713951B8/pt active IP Right Grant
- 2007-07-02 MY MYPI20085146 patent/MY150468A/en unknown
2008
- 2008-11-24 ZA ZA2008/09948A patent/ZA200809948B/en unknown
- 2008-12-08 IL IL195796A patent/IL195796A/en active IP Right Grant
- 2008-12-30 MA MA31527A patent/MA30540B1/fr unknown
2009
- 2009-01-20 NO NO20090312A patent/NO341709B1/no active Protection Beyond IP Right Term
2012
- 2012-05-04 US US13/463,978 patent/US20120316142A1/en not_active Abandoned
- 2012-11-29 CY CY20121101169T patent/CY1113733T1/el unknown
2020
- 2020-11-12 FR FR20C1054C patent/FR20C1054I1/fr active Active
- 2020-11-18 HU HUS2000043C patent/HUS2000043I1/hu unknown
- 2020-11-20 LU LU00185C patent/LUC00185I2/fr unknown
- 2020-11-23 NO NO2020041C patent/NO2020041I1/no unknown
- 2020-11-25 LT LTPA2020535C patent/LTC2044025I2/lt unknown
- 2020-11-26 CY CY2020038C patent/CY2020038I1/el unknown
- 2020-11-27 FI FIC20200047C patent/FIC20200047I1/fi unknown
- 2020-12-07 NO NO2020044C patent/NO2020044I1/no unknown
- 2020-12-07 LU LU00188C patent/LUC00188I2/en unknown
- 2020-12-08 FR FR20C1063C patent/FR20C1063I1/fr active Active
- 2020-12-09 HU HUS2000053C patent/HUS2000053I1/hu unknown
- 2020-12-14 CY CY2020041C patent/CY2020041I1/el unknown
- 2020-12-16 FI FIC20200050C patent/FIC20200050I1/fi unknown
- 2020-12-16 LT LTPA2020538C patent/LTPA2020538I1/lt unknown

Also Published As

Publication number	Publication date
BRPI0713951B1 (pt)	2019-08-13
IL195796A0 (en)	2009-09-01
HK1127597A1 (en)	2009-10-02
HRP20121074T1 (hr)	2013-01-31
SI2044025T1 (sl)	2013-01-31
NO341709B1 (no)	2018-01-02
BRPI0713951A2 (pt)	2012-12-04
LTPA2020538I1 (lt)	2021-01-11
NO20090312L (no)	2009-01-28
DK2044025T3 (da)	2013-01-14
CN101479245A (zh)	2009-07-08
NO2020041I1 (no)	2020-11-23
FR20C1054I1 (fr)	2020-12-25
CY2020041I2 (el)	2021-03-12
LTPA2020535I1 (lt)	2020-12-28
CY2020038I2 (el)	2021-03-12
LUC00188I2 (pl)	2024-07-01
EP2044025B1 (en)	2012-10-03
JP2009541455A (ja)	2009-11-26
EP2044025A1 (en)	2009-04-08
CY2020038I1 (el)	2021-03-12
CA2654801C (en)	2014-08-19
KR20090023651A (ko)	2009-03-05
US20120316142A1 (en)	2012-12-13
ZA200809948B (en)	2009-05-25
LTC2044025I2 (lt)	2022-10-10
BRPI0713951B8 (pt)	2021-05-25
JP5253392B2 (ja)	2013-07-31
KR101402398B1 (ko)	2014-06-03
CY1113733T1 (el)	2016-06-22
MA30540B1 (fr)	2009-06-01
HUS2000053I1 (hu)	2020-12-28
US20090325912A1 (en)	2009-12-31
NO2020044I1 (no)	2020-12-07
AU2007264946A1 (en)	2008-01-03
CY2020041I1 (el)	2021-03-12
FR20C1063I1 (fr)	2021-01-22
WO2008000839A1 (en)	2008-01-03
MY150468A (en)	2014-01-30
US8198450B2 (en)	2012-06-12
FIC20200047I1 (fi)	2020-11-27
HUS2000043I1 (hu)	2020-12-28
MX2008016542A (es)	2009-01-19
CN101479245B (zh)	2013-05-22
FIC20200050I1 (fi)	2020-12-16
PT2044025E (pt)	2012-12-17
IL195796A (en)	2016-03-31
ES2396987T3 (es)	2013-03-01
NZ573292A (en)	2011-03-31
AU2007264946B2 (en)	2011-01-20
LUC00185I2 (pl)	2024-07-01
CA2654801A1 (en)	2008-01-03

Publication	Publication Date	Title
IL194546A0 (en)	2009-08-03	Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL199853A (en)	2015-02-26	Converged history of 5-Hydroxy-Admentil-2-Reindeer and Pharmaceutical Preparation containing them
HUS2000053I1 (hu)	2020-12-28	Kinolinszármazékok és gyógyászati készítményeik
IL242883B (en)	2022-01-01	Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
EP2056835A4 (en)	2013-01-30	PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
IL193211A (en)	2013-07-31	Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
IL190292A (en)	2017-01-31	History of pyridopyrimidinone and their pharmaceutical preparations
IL192613A (en)	2015-11-30	Cycloalkylamines and their pharmaceutical compositions
IL206594A (en)	2015-05-31	The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
PL1861387T3 (pl)	2014-08-29	Pochodne benzoimidazolu i ich kompozycje farmaceutyczne
IL196267A0 (en)	2009-09-22	Indole derivatives and pharmaceutical compositions containing the same
SI2154966T1 (sl)	2014-02-28	Benzimidazoli in njihovi farmacevtski sestavki
IL232459A0 (en)	2014-06-30	Quinolone compound and pharmaceutical preparation
IL201894A0 (en)	2010-06-16	Quinolone compound and pharmaceutical composition
PT1861387E (pt)	2014-06-11	Derivados de benzimidazol e composições farmacêuticas dos mesmos
IL197273A0 (en)	2011-08-01	Pharmaceutical and sunscreen compositions comprising caspase-14
EP2070919A4 (en)	2010-05-05	SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
IL194906A0 (en)	2009-08-03	Triphenylmethylphosphonate ester derivatives and pharmaceutical compositions containing the same
GB0610090D0 (en)	2006-06-28	Particulate drug compositions and their uses
SI2220047T1 (sl)	2015-07-31	Derivati kinolina, farmacevtski sestavki, ki jih vsebujejo in njihova uporaba
IL196318A0 (en)	2009-09-22	(s)-(-)-amlodipine camsylate derivatives and pharmaceutical compositions containing
GB0614365D0 (en)	2006-08-30	Pharmaceutical compositions and their use
EP2114404A4 (en)	2010-03-03	COMPOUND AND PHARMACEUTICAL COMPOSITION
GB0701295D0 (en)	2007-02-28	Z-stilbenes derivatives and the pharmaceutical composition thereof
HK1147486A (en)	2011-08-12	Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof